Product Information
ERYTHROMYCIN DR 250 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $1.9250 per EA under NDC 69238147103. Its NADAC has been published 237 times since Mar 23, 2022.
FDA first approved this application on Jul 2, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238147103
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA210954FDA Approved
7/2/2019
TE Code
AB
On Market Since
7/7/2019
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN DR 250 MG TABLET has been published 237 times since Mar 23, 2022, and over the history we have for it it has declined 55.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9250 per EA |
|---|---|
| All-time high | $4.6777 (Jul 12, 2023) |
| All-time low | $1.6915 (Feb 18, 2026) |
| 52-week high | $2.4837 |
| 52-week low | $1.6915 |
| Median price | $2.9575 |
| Average price | $3.1534 |
| Largest weekly change | +41.1% (Mar 22, 2023) |
| Weeks tracked | 237 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals NY LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Erythromycin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN DR 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 250 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $1.9250 per EA (NDC 69238147103), effective Sep 30, 2026.
How has the price of ERYTHROMYCIN DR 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN DR 250 MG TABLET has declined 55.0%. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 250 MG TABLET?
Since Mar 23, 2022, the NADAC for ERYTHROMYCIN DR 250 MG TABLET has ranged from a low of $1.6915 (Feb 18, 2026) to a high of $4.6777 (Jul 12, 2023), with a median of $2.9575 per EA.
Are there cheaper alternatives to ERYTHROMYCIN DR 250 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 250 MG TABLET, is $1.9028 per EA — about 1% below ERYTHROMYCIN DR 250 MG TABLET.
Who manufactures ERYTHROMYCIN DR 250 MG TABLET?
ERYTHROMYCIN DR 250 MG TABLET (NDC 69238147103) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.